Big Pharma

topic on 10 shows · 16 statements across 16 episodes

We Live to Build American Optimist Masters of Scale the Startup Ideas Podcast Top Founders the MAD Podcast How I Built This the a16z Podcast All-In 20VC

16 statements about Big Pharma, every show

ALL-IN Assertion Contradicted
Paul: An NIH foundation holds $1.2 trillion in Big Pharma vaccine revenue
“There's an NIH foundation that has 1.2 trillion dollars in it given from Big Pharma for their share of the COVID vaccine.”
Rand Paul Sep 5, 2025 ▶ 51:53 Senator Rand Paul: Tariffs, Debt, China, and a Warning for America
Galloway: Breaking up Big Tech, Pharma, and agriculture is the best anti-inflation fix
“I think the best thing we could do for inflation would be a series of breaking up everything from big chicken and big pharma to big tech.”
Scott Galloway Oct 17, 2024 ▶ 11:16 Scott Galloway: Unfiltered lessons for business and life | Masters of Scale
a16z Insight
Branson says big pharma's scale turns AI into an unstoppable juggernaut
“You're surprised at the amount of time it takes for a message to percolate, but eventually everyone, everyone gets behind it, you know, then you've turned the ocean tank and then it's this unstoppable juggernaut, right? Yeah. Because there's a lot of capital a…”
Kim Branson Aug 1, 2024 ▶ 8:29 AI in Pharmaceutical R&D with Kim Branson
HOW I BUILT THIS Assertion Contradicted
Ecko: 1990 Big Pharma marketing graduates could start at $65K to $85K
“You could make, like, at that time, and graduating in 1990, 65 to 85,000 dollars, like, right out of school.”
Marc Ecko Jun 3, 2024 ▶ 13:42 ECKO UNLTD and COMPLEX: Marc Ecko
ALL-IN Insight
Ramaswamy: Big pharma incentives force employees to only take consensus risks
“People don't take risks unless they're the same risks that the other pharma companies are taking, because if you take the same risk and fail, but everybody else is failing in a therapeutic category at the same time, you're safe. But if you take a risk that oth…”
Vivek Ramaswamy Jul 21, 2023 ▶ 3:31 In conversation with Vivek Ramaswamy
ALL-IN Opinion
Chamath: COVID-19 vaccine push was a Big Pharma revenue grab
“It was a revenue grab by big pharma plastered with non-scientific thinking from a bunch of people who should have known better.”
Chamath Palihapitiya Jun 10, 2023 ▶ 6:11 E132: SEC goes after crypto giants, Sequoia splits, LIV/PGA, Messi's deal + LIVE Q&A!
Niedel: Big Pharma opposes Kratom because it treats opioid addiction
“Big Pharma doesn't like Kratom because it helps people get off of opioid addiction.”
Ryan Niedel Feb 1, 2023 ▶ 5:25 Every New Level Has a New Devil - He Proved It From $5M to $75M
Scotti: Americans Blame Big Pharma but Actually Suffer from Big PBMs
“All the time you hear Americans, you know, close to you walking around complaining about Big Pharma, and you, what you hear them complaining about is Big Pharma. What they're actually complaining about that they don't know is Big PBM and Big Pharmacy.”
Kimmy Scotti Jan 26, 2023 ▶ 11:31 Kimmy Scotti: How to Spot (and Build) the Next Big Thing · Joe Lonsdale
20VC Prediction Not checkable as stated
Cuban: Big pharma will match Cost Plus Drugs' pricing as scale grows
“A lot of them will match. Some of them will ignore us. It depends on how big we get. You know, if we have ten million customers, they'll pay attention to us. If we have a million customers, maybe not. You know, and there'll be times when there'll be PR and, yo…”
Mark Cuban Feb 8, 2022 ▶ 3:54 Cost Plus Drugs: EXPLAINED | Mark Cuban Full Interview · 20VC with Harry Stebbings
STARTUP IDEAS Prediction Not checkable as stated
Bloom: Psychedelics will fundamentally disrupt and replace psychiatric medications
“Science is starting to show in a meaningful way that psychedelic compounds can be extraordinarily useful for people dealing with depression. I mean, we're gonna, it's gonna completely separate and completely change antidepressants, anti-anxiety medicines, and …”
Sahil Bloom Nov 18, 2021 ▶ 10:41 The NSFW Framework & the Magic of Community-Product Fit with Amanda Goetz | Where It Happens
a16z Assertion Not checkable as stated
Biotech Boards Increasingly Retain U.S. Rights and Out-License Ex-U.S. Rights
“What we've seen really over the last 10 years is a lot of boards want the companies to be able to be standalone. And so, what you see are, in this fairly typical and actually Spark is a good example, where the company will keep commercial rights for the U.S. A…”
Koki Hirasaki Feb 28, 2019 ▶ 19:14 What’s with All the Bio M&A in 2019?: A Quick Take
a16z Prediction Not checkable as stated
Kindler: Future pharma innovation will originate outside big pharma incumbents
“I imagine a lot of this Innovation will come outside of big pharma, but the big pharma's that succeed will be the ones that get it.”
Jeff Kindler Jan 2, 2019 ▶ 27:19 a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology)
a16z Insight
Lowe: Tech-bio service pilot models fail to generate sustainable economics
“And they start as a service company. They start by saying, hey, I'm gonna go to big pharma. I have a new techno, technological breakthrough. I'm gonna sell that as a pilot to, as a service to big pharma companies. And then they can't generate the economics tha…”
Jeffrey Lowe Apr 30, 2018 ▶ 4:31 Shifting Risk Mindsets, from Tech to Bio
TOP FOUNDERS Disclosure
Bhardwaj: InnoPlexus serves around six major pharmaceutical clients
“So we have around six big pharma clients for various therapeutic areas.”
Gunjan Bhardwaj Feb 24, 2018 ▶ 7:08 945 He's Democratizing Health Data Across Big Pharma With 200 Customers, $3.5m Revenue
20VC Disclosure
Bryan Johnson: OS Fund built science investment frameworks using Big Pharma practices
“So we used we went out and analyzed a number of different decision-making processes for Big Pharma and Big Oil, how they actually gather data, process data, and make decisions. So we used decision analysis and created a model that helped guide us through what …”
Bryan Johnson Jan 25, 2016 ▶ 10:14 20VC: Bryan Johnson @ OS Fund & Braintree on Investing In The Operating Systems Of Life & Why VC Should All Be Open Source
MAD Assertion Partly supported
Mike Driscoll: Big pharma R&D cuts create data science recruiting opportunities
“Most big pharma actually have turned, reduced their investment in R&D, and many of, it's a great place to recruit data scientists is out of these pharma R&D labs.”
Mike Driscoll Dec 5, 2013 ▶ 35:20 Panel: Metamarkets, Kaggle and Quid // Data Driven NYC #4 // Mar 2012

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.